Tianshui Zhongxing Bio-technology Co.,Ltd.
Sembol: 002772.SZ
SHZ
7.08
CNYBugünkü piyasa fiyatı
-764.5012
F/K Oranı
44.3411
PEG Oranı
2.78B
MRK Kapağı
- 0.00%
DIV Verimi
Tianshui Zhongxing Bio-technology Co.,Ltd. (002772-SZ) Finansal Tablolar
Bilanço
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1323.5 | 1695.7 | 1858.6 | |||||||||||||
balance-sheet.row.short-term-investments | 0 | 285 | 369.5 | 263.4 | |||||||||||||
balance-sheet.row.net-receivables | 0 | 28.3 | 80.9 | 21.6 | |||||||||||||
balance-sheet.row.inventory | 0 | 1274.6 | 1255.5 | 1173.9 | |||||||||||||
balance-sheet.row.other-current-assets | 0 | 32.8 | 4.8 | 24.4 | |||||||||||||
balance-sheet.row.total-current-assets | 0 | 2659.2 | 3036.9 | 3078.5 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 2946.8 | 3074 | 3005.4 | |||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.intangible-assets | 0 | 334.4 | 342.4 | 350.6 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 334.4 | 342.4 | 350.6 | |||||||||||||
balance-sheet.row.long-term-investments | 0 | 123.7 | -285.2 | -170.9 | |||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 268.3 | |||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 9.7 | 401.1 | 19.3 | |||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 3414.6 | 3532.3 | 3472.8 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 0 | 6073.8 | 6569.1 | 6551.3 | |||||||||||||
balance-sheet.row.account-payables | 0 | 179.1 | 205.4 | 155.6 | |||||||||||||
balance-sheet.row.short-term-debt | 0 | 1009.7 | 980.4 | 422.6 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 1 | 1 | 0.7 | |||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 1074.5 | 1622.5 | 2330.7 | |||||||||||||
Deferred Revenue Non Current | 0 | 102.9 | 118.5 | 127.2 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 0 | 266.7 | 252.2 | 234.8 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 1074.7 | 1741 | 2480.6 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.3 | 0.3 | 0.3 | |||||||||||||
balance-sheet.row.total-liab | 0 | 2535.3 | 3184.5 | 3300.2 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.common-stock | 0 | 393.2 | 407.5 | 407.4 | |||||||||||||
balance-sheet.row.retained-earnings | 0 | 958.9 | 931.5 | 819.4 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 60 | 26.1 | 27.3 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2020.3 | 2016.6 | 1994.5 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 3432.5 | 3381.6 | 3248.6 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 6073.8 | 6569.1 | 6551.3 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 3 | 3.1 | 2.5 | |||||||||||||
balance-sheet.row.total-equity | 0 | 3435.5 | 3384.7 | 3251.1 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||
Total Investments | 0 | 408.7 | 84.3 | 92.5 | |||||||||||||
balance-sheet.row.total-debt | 0 | 2084.4 | 2602.9 | 2753.3 | |||||||||||||
balance-sheet.row.net-debt | 0 | 1045.9 | 1276.7 | 1158.1 |
Nakit Akış Tablosu
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 159.6 | 158.9 | 54.3 | |||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 268.9 | 275.4 | 257.5 | |||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -10.9 | -28 | |||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 10.9 | 28 | |||||||||||||
cash-flows.row.change-in-working-capital | 0 | -11.7 | -77.9 | -788.6 | |||||||||||||
cash-flows.row.account-receivables | 0 | 20.7 | -35.7 | 2.5 | |||||||||||||
cash-flows.row.inventory | 0 | -26.3 | -85.4 | -912.1 | |||||||||||||
cash-flows.row.account-payables | 0 | -6.1 | 43.2 | 121 | |||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.other-non-cash-items | 0 | 107.8 | 137.3 | 63.1 | |||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -107 | -245.9 | -286.5 | |||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 3 | 0.4 | |||||||||||||
cash-flows.row.purchases-of-investments | 0 | -400 | -1310 | -510 | |||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 450 | 1172.5 | 959.4 | |||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0.7 | |||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -57 | -380.4 | 164.1 | |||||||||||||
cash-flows.row.debt-repayment | 0 | -544.4 | -1520.6 | -680.8 | |||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.dividends-paid | 0 | -117.9 | -170.3 | -148.7 | |||||||||||||
cash-flows.row.other-financing-activites | 0 | -92.9 | 1323 | 1459.6 | |||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -755.2 | -367.9 | 630.1 | |||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.net-change-in-cash | 0 | -287.7 | -254.6 | 380.6 | |||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1038.5 | 1326.2 | 1580.8 | |||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1326.2 | 1580.8 | 1200.2 | |||||||||||||
cash-flows.row.operating-cash-flow | 0 | 524.5 | 493.7 | -413.7 | |||||||||||||
cash-flows.row.capital-expenditure | 0 | -107 | -245.9 | -286.5 | |||||||||||||
cash-flows.row.free-cash-flow | 0 | 417.5 | 247.8 | -700.2 |
Gelir Tablosu Satırı
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1928.1 | 1970.3 | 1556.1 | |||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1500.6 | 1468.8 | 1268.2 | |||||||||||||
income-statement-row.row.gross-profit | 0 | 427.5 | 501.5 | 288 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 0 | 0.6 | 33.7 | 4.5 | |||||||||||||
income-statement-row.row.operating-expenses | 0 | 247.2 | 231 | 187.4 | |||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1747.7 | 1699.8 | 1455.6 | |||||||||||||
income-statement-row.row.interest-income | 0 | 31.6 | 31 | 53.6 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 83.6 | 90.5 | 80.9 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -17.6 | -148.7 | -67.3 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.6 | 33.7 | 4.5 | |||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -17.6 | -148.7 | -67.3 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 83.6 | 90.5 | 80.9 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 268.9 | 275.4 | 257.5 | |||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | 0 | 180.4 | 307.6 | 121.6 | |||||||||||||
income-statement-row.row.income-before-tax | 0 | 162.8 | 158.9 | 54.3 | |||||||||||||
income-statement-row.row.income-tax-expense | 0 | 3.2 | 0 | 66.7 | |||||||||||||
income-statement-row.row.net-income | 0 | 159.6 | 158.4 | -12.4 |
Sıkça Sorulan Sorular
Nedir Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) toplam varlıklar?
Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) toplam varlıklar 6073765300.000 şeklindedir.
İşletmenin yıllık geliri nedir?
Yıllık gelir N/A'dur.
Firma kâr marjı nedir?
Firma kar marjı 0.149'dir.
Şirket serbest nakit akışı nedir?
Serbest nakit akışı 0.517'dur.
İşletme net kar marjı nedir?
Net kâr marjı -0.002'dir.
Firma toplam geliri nedir?
Toplam gelir 0.001'dur.
Nedir Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) net kar (net gelir)?
Net kar (net gelir) 159581340.000'dur.
Firmanın toplam borcu nedir?
Toplam borç 2084417918.000'dir.
Faaliyet giderleri rakamı nedir?
İşletme giderleri 247154405.000'dır.
Şirket nakit rakamı nedir?
İşletme içi nakit 0.000'tir.